Itraconazole vs. trimethoprim­sulfamethoxazole: a comparative cohort study of 200 patients with paracoccidioidomycosis

Borges, Sheila Rocha Conceição; Silva, Gilberto Marcelo Sperandio da; Chambela, Mayara da Costa; Oliveira, Raquel de Vasconcelos Carvalhães; Costa, Regina Lana Braga; Wanke, Bodo; Valle, Antonio Carlos Francesconi do.
Artículo en Inglés | ARCA | ID: arc-11185

Documentos relacionados

  1. Oral Paracoccidioidomycosis affecting women: A systematic review.
  2. Acute Paracoccidioidomycosis in a 40-Year-Old Man: A Case Report and Literature Review.
  3. Evaluation of the hepatobiliary system in patients with paracoccidioidomycosis treated with cotrimoxazole or itraconazole.
  4. Acute-subacute paracoccidioidomycosis: A paediatric cohort of 141 patients, exploring clinical characteristics, laboratorial analysis and developing a non-survival predictor.
  5. Paracoccidioidomycosis in Mexico: clinical and epidemiological data from 93 new cases (1972-2012).
  6. Evaluation of antifibrotic and antifungal combined therapies in experimental pulmonary paracoccidioidomycosis.
  7. Paracoccidioidomycosis.
  8. Itraconazole vs. trimethoprim-sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis.
  9. Hepatic Disease with Portal Hypertension and Acute Juvenile Paracoccidioidomycosis: A Report of Two Cases and Literature Review.
  10. Sarcoid-like cutaneous lesions in chronic adult paracoccidioidomycosis: report of two cases.